510(k) device
Rapid-i Kit
Vitrolife Sweden AB · Labware, Assisted Reproduction (MQK, Class II) · First FDA decision Dec 23, 2009, newest Jan 4, 2019Infertility
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
510(k) pathway
Device trials
45
Naming "Rapid-i"
MAUDE reports
0
Brand "Rapid-i", since 2015
PubMed studies
353
Mentioning "Rapid-i"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Rapid-i Kit
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- Rapid-i Kit510(k)
K181461 · Decided Jan 4, 2019 · 214 days after receipt
Device type: Labware, Assisted Reproduction (MQK) · Obstetrics & Gynecology
- RAPID-I KIT510(k)
K140207 · Decided Dec 18, 2014 · 324 days after receipt
Device type: Labware, Assisted Reproduction (MQK) · Obstetrics & Gynecology
- RAPID-I510(k)
K090832 · Decided Dec 23, 2009 · 272 days after receipt
Device type: Labware, Assisted Reproduction (MQK) · Obstetrics & Gynecology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Rapid-i", any status and sponsor, newest update first.
Riphah International UniversityAcademic, hospital or other
NCT07738627 · 65 participants (planned) · Start Aug 10, 2026 · Primary completion Jan 5, 2027
Device: POWERBREATH; SHAM IMT · For: Knee Osteoarthritis
Sites: Rawalpindi, Pakistan
- Ramadan Nutrition Plan (RNP) Education for Glycaemic Control in Older Adults With Type 2 Diabetes in YogyakartaPivotal-lookingNot yet recruiting
Universiti Putra MalaysiaAcademic, hospital or other
NCT07932210 · 133 participants (planned) · Start Dec 1, 2026 · Primary completion Mar 1, 2028
Device: Self-monitoring of blood glucose (SMBG) · For: T2DM (Type 2 Diabetes Mellitus); Ramadan Fasting
Sites: Sleman, Indonesia
Washington University School of MedicineAcademic, hospital or other
NCT06636175 · 21 participants · Start Mar 20, 2025 · Primary completion Aug 28, 2026
Device: PET/CT · For: Multiple Myeloma; Low-Grade Lymphoma; Follicular Lymphoma and 4 more
Sites: St Louis, Missouri
42 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Rapid-i", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code MQK
2 reports: 2 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Rapid-i"[tiab]. The summary above synthesizes these.
- Cardiovascular safety of antihistamines.
Olasiska-Wiśniewska A, Olasiski J, Grajek S · Postepy Dermatol Alergol · 2014Review
- Photodegradation of naphthalene-derived particle oxidation products.
Sari Doré F, Carstens C, Top J, et al. · Environ Sci Atmos · 2025
- ARA-C analogs.
Alberto P · Antibiot Chemother (1971) · 1978Clinical Trial, Review
- [Hypercalcemic crisis and hypocalcemic tetany].
Kasperk C · Internist (Berl) · 2017Review
- Imaging of benign hepatic masses.
Federle MP, Brancatelli G · Semin Liver Dis · 2001Review
- Rapid Adaption but Genetic Diversity Loss of a Globally Distributed Diatom in the Warmer Ocean.
Cheng L, Xu X, Wang M, et al. · Glob Chang Biol · 2024Research Support, Non-U.S. Gov't
- Bretylium tosylate: a review.
Bryan CK, Darby MH · Am J Hosp Pharm · 1979Review
- Ultrafast current imaging by Bayesian inversion.
Somnath S, Law KJH, Morozovska AN, et al. · Nat Commun · 2018Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
- Individualized stress detection using an unmodified car steering wheel.
Balters S, Gowda N, Ordonez F, et al. · Sci Rep · 2021Research Support, Non-U.S. Gov't
- Interleukins. Clinical pharmacokinetics and practical implications.
Bocci V · Clin Pharmacokinet · 1991Research Support, Non-U.S. Gov't, Review
- Appendix E: Rapid-iTM: Closed Vitrification Device by Vitrolife.
Larman MG · Methods Mol Biol · 2017
Other devices of this type
Also filed under product code MQK.
- VitriGuardOrigio A/S · 510(k) 2020
- Pleiades DeviceMy123Baby Medical Limited Dba Boost Fertility · 510(k) 2026
- CyperusContrario Medical, Inc. · 510(k) 2026
- Fertilis microICSI DeviceFertilis Pty, Ltd. · 510(k) 2026
- SperSort Sperm Sorting Chip (IPG02)Ipreg Incorporation · 510(k) 2025
- Minvitro® Vitrification Straw (MVT-VSN series, including MVT-VSNRGuangzhou Hehong Biotech Co., Ltd. · 510(k) 2025
- SwimCount® Harvester (1 mL)Motilitycount Aps · 510(k) 2025
- cryo-GO Vitrification DeviceFujifilm Irvine Scientific · 510(k) 2024
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.